Companies
MRNS’s Q2 earnings predictions: What the experts say
Currently, Marinus Pharmaceuticals Inc’s (MRNS) stock is trading at $1.46, marking a gain of 3.55% from last night’s close. At this price, the stock is
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.